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Abstract
Background: There is limited data on Methicillin resistant Staphylococcus aureus (MRSA) in Uganda where, as in
most low income countries, the routine use of chromogenic agar for MRSA detection is not affordable. We aimed
to determine MRSA prevalence among patients, healthcare workers (HCW) and the environment in the burns units
at Mulago hospital, and compare the performance of CHROMagar with oxacillin for detection of MRSA.
Results: One hundred samples (from 25 patients; 36 HCW; and 39 from the environment, one sample per person/
item) were cultured for the isolation of Staphylococcus aureus. Forty one S. aureus isolates were recovered from 13
patients, 13 HCW and 15 from the environment, all of which were oxacillin resistant and mecA/femA/nuc-positive.
MRSA prevalence was 46% (41/89) among patients, HCW and the environment, and 100% (41/41) among the
isolates. For CHROMagar, MRSA prevalence was 29% (26/89) among patients, HCW and the environment, and 63%
(26/41) among the isolates. There was high prevalence of multidrug resistant isolates, which concomitantly
possessed virulence and antimicrobial resistance determinants, notably biofilms, hemolysins, toxin and ica genes.
One isolate positive for all determinants possessed the bhp homologue which encodes the biofilm associated
protein (BAP), a rare finding in human isolates. SCCmec type I was the most common at 54% prevalence (22/41),
followed by SCCmec type V (15%, 6/41) and SCCmec type IV (7%, 3/41). SCCmec types II and III were not detected
and 10 isolates (24%) were non-typeable.
Conclusions: Hyper-virulent methicillin resistant Staphylococcus aureus is prevalent in the burns unit of Mulago
hospital.
Background
There is a global outbreak of Methicillin resistant
Staphylococcus aureus (MRSA) infections, particularly in
industrialized countries [1]. However, there is limited
data on MRSA prevalence in Uganda, where ~10% of
the surgical procedures become septic with S. aureus
being the most frequent pathogen isolated [2-4].
Ojulong et al. 2009 determined the prevalence of MRSA
in patients with post-operative surgical wound infections
in the surgical wards of Mulago hospital in Kampala,
Uganda [5], but the distribution of isolates among
healthcare workers (HCW) and the environment was
not determined. Here, we aimed to determine MRSA
prevalence among patients, HCW and the environment
in the burns units at Mulago hospital, and compare the
performance of CHROMagar with oxacillin for detection
of MRSA (since the routine use of chromogenic agar is
usually not affordable in most low income settings).
Methods
Study setting and sampling
This cross-sectional study was performed during
November, 2009 and February, 2010 in the two surgical
units specializing in the treatment of patients with
burns at Mulago national referral hospital in Kampala,
Uganda. Ethical approval was obtained from the Depart-
ment of Surgery, Mulago Hospital, and the Research
and Ethics Committee of Makerere University College
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patients and HCW. Patients and HCW enrolled had
stayed in the hospital units for at least 72 hours. HCW
included doctors, nurses and nursing aids that had
direct involvement with patients. For the environment,
surfaces of frequently handled items (door handles,
sinks, surgical trays, beds and table surfaces) were
swabbed, as well as air samples on settle plates (with
blood agar). For patients, wounds or nostrils were
swabbed while for HCW, hands or nostrils were
swabbed. One hundred samples (one sample per person
o ri t e m )f r o m2 5p a t i e n t s ,3 6H C Wa n d3 9i t e m s
(including air settle plates) were obtained using sterile
swabs and transported to the laboratory for culture in
tubes containing Amies transport medium (Biolab,
Budapest, Hungary).
Cultures and drug susceptibility testing (DST)
Swabs were cultured on blood agar and Mannitol salt
agar at 37°C for 24 hours, ensuring growth of distinct
colonies. The predominant colony type per sample was
selected, and S. aureus was identified to species level
microbiologically as previously described [6]. Drug sus-
ceptibility testing (erythromycin, 15 μg; vancomycin,
30 μg; gentamicin, 10 μg; oxacillin, 1 μg; tetracycline,
30 μg; chloramphenicol, 30 μg; penicillin, 10 units; and
sulphamethoxazole-trimethoprim, 1.25/23.15 μg) was
performed with the disc diffusion method (Biolab inc,
Budapest, Hungary). Isolates resistant to erythromycin
were screened for the macrolide-lincosamide and
streptrogramin B (MLSB) phenotype. MRSA was iden-
tified based on oxacillin resistance following standard
procedures [7], and confirmed by PCR detection of the
mecA gene. For comparison, oxacillin resistant-mecA
positive isolates were further screened for growth on
CHROMagar (BD diagnostics, Sparks, USA).
SCCmec genotyping
Staphylococcus Cassette Chromosomal mec (SCCmec)
genotyping was performed in a multiplex PCR protocol
described by Boye et al, 2007 (see additional file 1 for
primers and PCR conditions) [8]. The SCCmec types
were determined based on the banding patterns upon
agarose gel electrophoresis of the amplicons [8]. Isolates
with no visible bands were classified as non-typeable [8].
Detection of virulence determinants
Biofilms
Biofilms were detected with the microtiter plate method
[9] and the biofilm unit calculated according to Amaral
et al. [10]. Briefly, assays were performed in triplicates
in tryptic soya broth (TSB) with 1% glucose in 96-well
polystyrene flat-bottom tissue culture plates. Isolates
were incubated at 37°C overnight with gentle shaking
and standardized to OD600 = 0.005 with normal saline.
Then, 50 μl of standardized cells mixed with 150 μl
TSB/1% glucose were incubated at 37°C for 17 hr. After
washing three times with sterile water and staining with
crystal violet for 15 minutes, cells were washed again
and incubated at room temperature for 1 hr in 95%
ethanol. Then, biofilms were measured with a spectro-
photometer at OD570. The biofilm unit (BU) was calcu-
lated using negative control values with the formula A1/
A2,w h e r eA 1 is the test value while A2 is the negative
control value. Isolates with BU > 2× the negative control
value were considered biofilm producers and were clas-
sified as: weak, 0.182 < BU < 0.364; moderate, 0.364 <
BU < 0.728; strong, BU > 0.728 [10]. The biofilm form-
ing S. epidermidis RP62A and its non-biofilm forming
variant (ATCC 12228) were used as controls.
Virulence and antimicrobial resistance genes
Molecular assays for the detection of virulence asso-
ciated genes, ica (intercellular adhesion); cna (collagen
adhesion [11]); hemolysins (hla, hlb, hld, hlg [12]); sdrE
(serine-aspartate repeat protein E [11]); PVL (Panton-
Valentine leukocidin [13]); and S. aureus super-antigenic
toxins (tst, toxic shock syndrome toxin [12,14] and sea,
staphylococcal enterotoxin A [12,14]) were performed
with primers and conditions described in literature (also
see additional file 1). To detect genes encoding amino-
glycoside-modifying enzymes (AMEs) [15], PCR on aac
(6’)-Ie-aph(2’’)-Ia (bifunctional aminoglycoside-6-N-acet-
yltransferase/2’’-O- phosphoryltransferase), aph(3’)-IIIa
(aminoglycoside-3’-O-phosphoryltransferase III) and ant
(4’)-Ia (aminoglycoside-4’-O-nucleotidyltransferase I)
was performed. Presence of mecA (the molecular deter-
minant of methicillin resistance), vanA/vanB1 (encode
vancomycin resistance variants) and blaZ (encodes b-
lactamase) was also determined by PCR. For mecA gen-
otyping, methicillin resistant S. aureus (MRSA-252) and
methicillin sensitive S. aureus (MSSA, ATCC 29213)
were used as positive and negative controls, respectively.
For analysis, amplicons were electrophoresed on 1%
agarose gels in TBE (Tris borate and EDTA) and repre-
sentative samples sequence-confirmed. The data was
analyzed with GraphPad Prism 5 software and presented
graphically. Primers and PCR conditions are described
in additional file 1. To minimize cross-contamination,
DNA extraction and PCR-amplifications were performed
in molecular laboratories that are separate from the clin-
ical microbiology laboratory where cultures were grown.
The PCR laboratory has designated sections for pre-
amplification, amplification and post-amplification.
Results
Gram positive isolates grew from 62 samples but 11 were
lost (five from HCW, four from patients and two from the
environment), leaving 51 samples that were completely
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from patients (67%, 14/21; 4 from nostrils and 10 from
wounds), 13 from HCW (42%, 13/31; 5 from nostrils and
8 from finger swabs), and 14 from the environment (38%,
14/37, see Table 1). Each isolate grew from a distinct sam-
ple per person or item. Thus, the prevalence of S. aureus
in the burns unit was 46% (41/89), (Table 1).
All the 41 isolates were sensitive to vancomycin; con-
versely, all the isolates were oxacillin resistant and
mecA/nuc/femA-positive (implying they were S. aureus),
revealing an MRSA prevalence of 46% (41/89) in the
burns unit (i.e., among patients, HCW and environ-
ment) and 100% (41/41) among isolates (see table 1).
SCCmec type I was the most common at 54% preva-
lence (22/41), followed by SCCmec type V (15%, 6/41)
and SCCmec type IV (7%, 3/41). SCCmec types II and
III were not detected and 10 isolates (24%) were non-
typeable (see table 1). For CHROMagar, only 26 isolates
grew with the characteristic mauve color indicative of
M R S A ,r e v e a l i n gap r e v a l e n c eo f2 9 %i nt h eu n i t( i . e . ,
among patients, HCW and environment) and 63% (26/
41) among isolates.
Overall, 26 six isolates (63%, 26/41) MDR with the com-
monest pattern being resistance to b-lactams, sulpha-
methoxazole-trimethoprim (SXT) and tetracycline.
Indeed, resistance to penicillin, tetracycline and SXT was
high (93%, 38/41; 68%, 28/41 and 66%, 27/41 prevalence,
respectively); resistance to penicillin correlated with the
high prevalence of blaZ gene (93%, 38/41, see Figure 1).
Conversely, erythromycin, gentamicin and chlorampheni-
col resistance was relatively low (29%, 12/41; 20%, 8/41
and 20%, 8/41 prevalence respectively) and correlated with
that of the AMEs encoding genes: aac(6’)-Ie-aph(2’’)-Ia
(61%, 25/41); aph(3’)-IIIa (34%, 14/41); and ant(4’)-Ia
(20%, 10/20), which are associated with aminoglycoside
resistance [16]. With the exception of one isolate, all the
isolates possessing AMEs encoding genes were concomi-
tantly ica-positive. Additionally, three isolates resistant to
erythromycin gave a positive D-test indicating possible
cross-resistance to macrolide-lincosamide-streptogramin
(MLSB) antibiotics in this setting [17].
Most isolates were strongly biofilm-positive (100%,
41/41, see Figure 1) and nearly all had the ica genes (93%,
38/41, with only three testing negative); only one of the
two ica-negative isolates was MDR. Furthermore, all the
isolates exhibited b-hemolysis on blood agar (100%, 41/41)
and this correlated with the high prevalence of the genes
encoding hemolysins: hla, 100% (41/41); hld, 100%
(41/41); and hlg, 61% (25/41)). Many isolates possessed
additional virulence genes: sea, 85% (35/41); sdrE, 83%
(34/41); and PVL, 73% (30/41), while cna and tsst were
less prevalent (29%, 12/41 and 10%, 4/41 respectively).
Thirty four (83%, 34/41) isolates were ica/sdrE-positive; 33
(80%, 33/41) ica/sea-positive; 28 (68%, 28/41) ica/PVL-
positive; 23 (56%, 23/41) ica/hlg-positive and three (7%, 3/
41) ica/tsst-positive. All the 12 (29%, 12/41) cna-positive
isolates were also ica-positive. Interestingly, an isolate
positive for all the determinants studied possessed the
homologue of the bhp gene, which encodes the biofilm
associated protein (BAP); this is rarely detected in human
isolates but frequently detected in staphylococci causing
bovine mastitis [18]. This bhp-positive isolate was MDR
and negative for only three determinants, tst, aph(3’)-IIIa
and ant(4’)-Ia, conforming to its susceptibility to erythro-
mycin/gentamicin. Detailed analyses for the virulence and
antimicrobial resistance determinants are provided in
additional file 2.
Discussion
In this study, high prevalence of MDR-MRSA was found
in the burns unit of Mulago hospital, predisposing
patients to infection with intractable isolates and under-
scoring the need for improved infection control practices
in this setting. Ojulong et al 2009, reported a relatively
lower prevalence (31.6%) from the general surgery ward,
possibly because this earlier study determined MRSA
infections in only patients with post-operative surgical
wound infections [5]. Although data are still limited,
there are emerging reports of prevalent MRSA infections
in sub-Saharan Africa [19].
CHROMagar, generally considered more efficient at
detecting MRSA than oxacillin discs [20] was inefficient
Table 1 MRSA prevalence (%) and SCCmec types among isolates from the burns units at Mulago hospital
Oxacillin disc CHROMagar SCCmec types
Sample source (n = 89) S. aureus
1 mecA MSSA MRSA MSSA MRSA I II III IV V NT
Patients
(n = 21)
14 14 ND 14 4 10 8 ND ND 3 1 2
HCW
(n = 31)
13 13 ND 13 4 9 8 ND ND ND 3 2
Environment
(n = 37)
14 14 ND 14 7 7 6 ND ND ND 2 6
Prevalence 46
(41/89)
100
(41/41)
46
(41/89)
17
(15/89)
29
(26/89)
54
(22/41)
-- 7
(3/41)
15
(6/41)
24
(10/41)
1Isolates per sample; ND, Not detected; HCW, healthcare worker; NT, Not typeable
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Since all isolates were oxacillin resistant, mecA-positive
(mecA encodes the penicillin binding protein 2a, the
molecular determinant for methicillin resistance [21]),
nuc- and femA-positive, they were confirmed as MRSA.
Prior to use, the CHROMagar batch passed quality con-
trol screening with known MRSA and MSSA strains; yet
only 26 isolates grew mauve colonies (which is indica-
tive of MRSA); the use CHROMagar in this setting may
need further investigations.
A high prevalence of biofilm/ica-positive isolates corre-
lated with that of MDR isolates. Although biofilms/ica
genes are debatable as virulence markers [22], in this
study, the biofilm/ica-positive isolates were concomi-
tantly positive for other virulence genes. Notably was the
absolute prevalence for staphylococcal hemolysins: hla
and hld.T h ehla gene encodes a dermanecrotic and neu-
rotoxic toxin that is also responsible for abscess forma-
tion; hld producing S. aureus can cause severe enteritis,
while hlg lyses mammalian red blood cells and together
with tst-1 (toxic shock syndrome toxin-1), can be
involved in the pathogenesis of toxic shock syndrome
(TSS) [15]. PVL, also prevalent in this study, causes
severe disease in children and young adults with no
known exposure to healthcare establishment, and is used
as a stable marker for community acquired MRSA [15].
Furthermore, the staphylococcal super-antigenic toxins,
sea and tst-1 were also detected (85% and 10% prevalence
respectively). sea producing strains are responsible for
staphylococcal food intoxications, while tst strains pro-
duce antigens that are responsible for TSS.
Conclusion
Hypervirulent methicillin resistant S. aureus is prevalent
in the burns unit of Mulago hospital.
Additional material
Additional file 1: Primers and PCR conditions.
Additional file 2: Speciation, drug susceptibility testing and
detection of virulence and antimicrobial resistance genes/
determinants. NA, Not applicable; ND, Not detected; MSSA, Methicillin
Sensitive Staphylococcus aureus; MRSE, Methicillin Resistance
Staphylococcus epidermidis.
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